v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 161,744 $ 97,219 $ 414,918 $ 302,902
General and administrative 35,330 16,673 89,093 49,153
Total operating expenses 197,074 113,892 504,011 352,055
Loss from operations (197,074) (113,892) (504,011) (352,055)
Other income (expense):        
Interest income 9,767 8,476 26,312 22,202
Interest expense (5,949) (2,904) (14,746) (2,998)
Other income (expense), net (296) 279 (517) (1,408)
Total other income, net 3,522 5,851 11,049 17,796
Net loss $ (193,552) $ (108,041) $ (492,962) $ (334,259)
Net loss per share - basic $ (1.06) $ (0.76) $ (2.89) $ (2.74)
Net loss per share - diluted $ (1.06) $ (0.76) $ (2.89) $ (2.74)
Weighted average common shares outstanding, basic 181,765,918 141,810,881 170,809,706 121,980,400
Weighted average common shares outstanding, diluted 181,765,918 141,810,881 170,809,706 121,980,400
Comprehensive loss:        
Net Income (Loss) $ (193,552) $ (108,041) $ (492,962) $ (334,259)
Other comprehensive loss:        
Unrealized gains (losses) on marketable securities, net (650) 244 (1,478) 490
Comprehensive loss $ (194,202) $ (107,797) $ (494,440) $ (333,769)